المؤلفون: De Caterina, R., Kelly, P., Monteiro, P., Deharo, J. C., de Asmundis, C., López-De-Sá, E., Weiss, T. W., Waltenberger, J., Steffel, J., de Groot, J. R., Levy, P., Bakhai, A., Zierhut, W., Laeis, P., Kerschnitzki, M., Reimitz, P. -E., Kirchhof, P., on behalf of the ETNA-AF-Europe investigators

المساهمون: De Caterina, R., Kelly, P., Monteiro, P., Deharo, J. C., de Asmundis, C., López-De-Sá, E., Weiss, T. W., Waltenberger, J., Steffel, J., de Groot, J. R., Levy, P., Bakhai, A., Zierhut, W., Laeis, P., Kerschnitzki, M., Reimitz, P. -E., Kirchhof, P., on behalf of the ETNA-AF-Europe, Investigators

مصطلحات موضوعية: Non-vitamin K antagonist oral anticoagulants, Real-world, Registry, Stroke prevention, Majorbleeding, Safety outcomes

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31299906; info:eu-repo/semantics/altIdentifier/wos/WOS:000475528100003; volume:19; issue:1; numberofpages:11; journal:BMC CARDIOVASCULAR DISORDERS; http://hdl.handle.net/11568/1097440Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85068940967; https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-1144-xTest

الإتاحة: https://doi.org/10.1186/s12872-019-1144-xTest
http://hdl.handle.net/11568/1097440Test

المؤلفون: ETNA-AF-Europe investigators, De Caterina, Raffaele, Kelly, Peter, Monteiro, Pedro, Deharo, Jean Claude, de Asmundis, Carlo, López-de-Sá, Esteban, Weiss, Thomas W, Waltenberger, Johannes, Steffel, Jan, de Groot, Joris R, Levy, Pierre, Bakhai, Ameet, Zierhut, Wolfgang, Laeis, Petra, Kerschnitzki, Michael, Reimitz, Paul-Egbert, Kirchhof, Paulus

المساهمون: Clinical sciences, Heartrhythmmanagement, University of Zurich, Kirchhof, Paulus, Cardiology, ACS - Heart failure & arrhythmias

المصدر: BMC Cardiovascular Disorders
BMC cardiovascular disorders, 19(1):165. BioMed Central
BMC Cardiovascular Disorders, Vol 19, Iss 1, Pp 1-11 (2019)

مصطلحات موضوعية: Male, lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, Pyridines, Administration, Oral, 030204 cardiovascular system & hematology, Major bleeding, chemistry.chemical_compound, 0302 clinical medicine, Edoxaban, Risk Factors, Stroke prevention, Atrial Fibrillation, Medicine, 030212 general & internal medicine, Registries, Practice Patterns, Physicians', Stroke, Medicine(all), Aged, 80 and over, education.field_of_study, Anticoagulant, Atrial fibrillation, Middle Aged, Cardiac surgery, Europe, Treatment Outcome, Practice Guidelines as Topic, 10209 Clinic for Cardiology, Female, Guideline Adherence, Cardiology and Cardiovascular Medicine, Majorbleeding, Research Article, medicine.medical_specialty, Registry, medicine.drug_class, Population, 610 Medicine & health, Hemorrhage, Risk Assessment, 2705 Cardiology and Cardiovascular Medicine, 03 medical and health sciences, Internal medicine, Product Surveillance, Postmarketing, Humans, Medical prescription, education, Angiology, Aged, Drug Labeling, business.industry, Safety outcomes, Non-vitamin K antagonist oral anticoagulants, Real-world, Registry, Stroke prevention, Majorbleeding, Safety outcomes, medicine.disease, Drug Utilization, Thiazoles, chemistry, Real-world, lcsh:RC666-701, Non-vitamin K antagonist oral anticoagulants, business, Factor Xa Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f63d08e2d391adf6c8d2957ae4c458bfTest
http://europepmc.org/articles/PMC6625115Test